SCHEMBL5504643

SCHEMBL5504643

CCCCOC(=O)N1CCCC([C@@](O)(CCCCOC)c2ccccc2Oc2cccc(F)c2)C1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.60
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2846448 0.90 REN (0.64) RENCYP3A4
SCHEMBL2846452 0.90 REN (0.64) RENCYP3A4
SCHEMBL1861558 0.90 REN (0.64) RENCYP3A4
SCHEMBL1861560 0.90 REN (0.64) RENCYP3A4
SCHEMBL4755380 0.89 REN (0.68) RENCYP3A4
SCHEMBL1863848 0.89 REN (0.68) RENCYP3A4
SCHEMBL4298773 0.85 REN (0.65) REN
SCHEMBL4292054 0.85 REN (0.65) REN
SCHEMBL4292048 0.85 REN (0.65) REN
SCHEMBL1865004 0.85 REN (0.84) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807078-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2007-07-18 EP disclosed
WO-2006042150-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-04-20 WO disclosed